固體生物科學公司
US ˙ NasdaqGS ˙ US83422E2046

簡介

本頁面提供了有關 David T Howton 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示David T Howton已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:SLDB / Solid Biosciences Inc. Chief Operating Officer 105,077
US:SRPT / Sarepta Therapeutics, Inc. EVP, General Counsel 7,708
US:VRTX / Vertex Pharmaceuticals Incorporated SVP & Chief Legal Officer 68,750
如何解讀這些圖表

以下圖表顯示了在David T Howton進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

SLDB / Solid Biosciences Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 SLDB / Solid Biosciences Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

SLDB / Solid Biosciences Inc. Insider Trades
SLDB / Solid Biosciences Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 SLDB / Solid Biosciences Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2026-02-18 SLDB Howton David T 7,469 5.8233 7,469 5.8233 43,494 15 5.6100 -1,593 -3.66
2026-02-04 SLDB Howton David T 18,894 6.4419 18,894 6.4419 121,713
2026-02-02 SLDB Howton David T 37,771 6.4369 37,771 6.4369 243,128
2025-12-03 SLDB Howton David T 4,932 5.1100 4,932 5.1100 25,203
2025-02-14 SLDB Howton David T 5,561 3.9600 5,561 3.9600 22,022
2024-12-03 SLDB Howton David T 5,072 5.5986 5,072 5.5986 28,396

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

SLDB / Solid Biosciences Inc. Insider Trades
歷史內部人交易

該表格顯示了由 David T Howton 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-02-18 2026-02-18 4 SLDB Solid Biosciences Inc.
Common Stock
S - Sale -7,469 105,077 -6.64 5.82 -43,494 611,895
2026-02-18 2026-02-13 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 14,687 112,546 15.01
2026-02-06 2026-02-04 4 SLDB Solid Biosciences Inc.
Common Stock
S - Sale -18,894 97,859 -16.18 6.44 -121,713 630,398
2026-02-02 2026-02-02 4 SLDB Solid Biosciences Inc.
Common Stock
S - Sale -37,771 116,753 -24.44 6.44 -243,128 751,527
2026-02-02 2026-01-31 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 42,275 154,254 37.75
2026-02-02 2026-01-29 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 79,341 112,249 241.10
2025-12-04 2025-12-03 4 SLDB Solid Biosciences Inc.
Common Stock
S - Sale -4,932 32,908 -13.03 5.11 -25,203 168,160
2025-12-04 2025-12-02 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 13,051 37,840 52.65
2025-02-18 2025-02-14 4 SLDB Solid Biosciences Inc.
Common Stock
S - Sale -5,561 24,789 -18.32 3.96 -22,022 98,164
2025-02-18 2025-02-13 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 14,687 30,350 93.77
2024-12-04 2024-12-03 4 SLDB Solid Biosciences Inc.
Common Stock
S - Sale -5,072 15,663 -24.46 5.60 -28,396 87,691
2024-12-04 2024-12-02 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 13,051 20,735 169.85
2023-12-05 2023-12-04 4 SLDB Solid Biosciences Inc.
Common Stock
S - Sale X -5,367 7,684 -41.12 2.78 -14,920 21,362
2023-12-05 2023-12-02 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 13,051 13,051
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -45,000 7,708 -85.38
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -56,984 0 -100.00
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -1,858 0 -100.00
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -1,280 0 -100.00
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -55,270 31,871 -63.43 171.50 -9,478,805 5,465,876
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -35,757 87,141 -29.09 170.59 -6,099,787 14,865,383
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -8,086 122,898 -6.17 169.56 -1,371,062 20,838,585
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -6,009 130,984 -4.39 168.61 -1,013,177 22,085,212
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 45,000 136,993 48.92 29.03 1,306,350 3,976,907
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 56,984 91,993 162.77 23.85 1,359,068 2,194,033
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 1,858 35,009 5.60 13.71 25,473 479,973
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 1,280 33,151 4.02 13.71 17,549 454,500
2020-02-28 2020-02-28 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
A - Award 37,500 37,500
2020-02-28 2020-02-28 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
A - Award 6,700 31,871 26.62
2019-12-17 2019-12-13 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -59,421 56,984 -51.05
2019-12-17 2019-12-13 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -18,579 0 -100.00
2019-12-17 2019-12-13 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -78,000 25,171 -75.60 125.50 -9,789,000 3,158,960
2019-12-17 2019-12-13 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 59,421 103,171 135.82 23.85 1,417,191 2,460,628
2019-12-17 2019-12-13 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 18,579 43,750 73.81 13.90 258,248 608,125
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise -7,900 5,118 -60.69
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise -5,590 0 -100.00
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise -52 18 -74.29
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise -2,440 2,470 -49.69
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -8,580 18,579 -31.59
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -4,025 1,858 -68.42
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -5,685 1,280 -81.62
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -2,804 25,171 -10.02 107.02 -300,084 2,693,800
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 7,900 27,975 39.35 23.85 188,415 667,204
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 5,590 20,075 38.59 13.90 77,701 279,042
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 52 14,485 0.36 13.71 713 198,589
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 2,440 14,433 20.35 13.71 33,452 197,876
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -2,957 11,993 -19.78 105.00 -310,485 1,259,265
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -3,753 14,950 -20.07 105.00 -394,065 1,569,750
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -18,290 18,703 -49.44 105.00 -1,920,450 1,963,815
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 8,580 36,993 30.20 13.90 119,262 514,203
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 4,025 28,413 16.50 13.71 55,183 389,542
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 5,685 24,388 30.40 13.71 77,941 334,359
2019-03-29 2019-03-28 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -2,362 18,703 -11.21 118.68 -280,322 2,219,672
2019-03-29 2019-03-28 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
A - Award 5,319 21,065 33.78
2019-03-04 2019-03-04 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
A - Award 45,000 45,000
2019-03-04 2019-02-28 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
D - Sale to Issuer -3,825 15,746 -19.54
2019-02-01 2019-02-01 4 SRPT Sarepta Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -16,827 116,405 -12.63 23.85 -401,324 2,776,259
2019-02-01 2019-02-01 4 SRPT Sarepta Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1,548 5,883 -20.83 13.71 -21,223 80,656
2019-02-01 2019-02-01 4 SRPT Sarepta Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -3,125 6,965 -30.97 13.71 -42,844 95,490
2019-02-01 2019-02-01 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -30,000 19,571 -60.52 140.00 -4,200,000 2,739,940
2019-02-01 2019-02-01 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 16,827 49,571 51.39 23.85 401,324 1,182,268
2019-02-01 2019-02-01 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 1,548 32,744 4.96 13.71 21,223 448,920
2019-02-01 2019-02-01 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 3,125 31,196 11.13 13.71 42,844 427,697
2018-08-08 2018-08-08 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -6,800 28,071 -19.50 121.02 -822,936 3,397,152
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -37,848 27,159 -58.22 13.90 -526,087 377,510
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -9,056 10,090 -47.30 13.71 -124,158 138,334
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -3,096 7,431 -29.41 13.71 -42,446 101,879
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -37,848 34,871 -52.05 136.46 -5,164,738 4,758,497
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 37,848 72,719 108.54 13.90 526,087 1,010,794
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -9,056 34,871 -20.62 136.46 -1,235,782 4,758,497
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 9,056 43,927 25.97 13.71 124,158 602,239
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -3,096 34,871 -8.15 136.46 -422,480 4,758,497
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 3,096 37,967 8.88 13.71 42,446 520,528
2018-05-24 2018-05-22 4 SRPT Sarepta Therapeutics, Inc.
Restricted Stock Units
M - Exercise -5,319 0 -100.00
2018-05-24 2018-05-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -1,566 34,871 -4.30 89.22 -139,719 3,111,191
2018-05-24 2018-05-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 5,319 36,437 17.09
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise -2,074 13,018 -13.74
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise -403 5,590 -6.72
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise -23 70 -24.73
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -609 31,118 -1.92 81.22 -49,463 2,527,404
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 2,074 31,727 6.99 23.85 49,465 756,689
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -68 29,653 -0.23 81.22 -5,523 2,408,417
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 403 29,721 1.37 13.90 5,602 413,122
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -3 29,318 -0.01 81.22 -244 2,381,208
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 23 29,321 0.08 13.71 315 401,991
2018-03-07 2018-03-05 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
A - Award 70,000 70,000
2017-08-07 2017-08-03 4 SRPT Sarepta Therapeutics, Inc.
Restricted Stock Units
M - Exercise -10,639 0 -100.00
2017-08-07 2017-08-03 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -4,642 29,298 -13.68 37.88 -175,839 1,109,808
2017-08-07 2017-08-03 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 10,639 33,940 45.66
2017-07-21 2017-07-21 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
M - Exercise -676 15,092 -4.29 23.85 -16,123 359,944
2017-07-21 2017-07-21 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
M - Exercise -324 93 -77.70 13.71 -4,442 1,275
2017-07-21 2017-07-21 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 676 23,301 2.99 23.85 16,123 555,729
2017-07-21 2017-07-21 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 324 22,625 1.45 13.71 4,442 310,189
2017-07-21 2017-07-20 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Options (right to buy)
M - Exercise X -5,944 19,146 -23.69 13.71 -81,492 262,492
2017-07-21 2017-07-20 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Options (right to buy)
M - Exercise X -19,056 10,527 -64.42 13.71 -261,258 144,325
2017-07-21 2017-07-20 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -5,944 22,301 -21.04 41.00 -243,704 914,341
2017-07-21 2017-07-20 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 5,944 28,245 26.65 13.71 81,492 387,239
2017-07-21 2017-07-20 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -19,056 22,301 -46.08 41.00 -781,296 914,341
2017-07-21 2017-07-20 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 19,056 41,357 85.45 13.71 261,258 567,004
2017-03-21 2017-03-19 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -152 22,301 -0.68 30.30 -4,606 675,720
2017-03-14 2017-03-10 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
A - Award 4,411 4,411
2017-03-14 2017-03-10 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 25,589 25,589
2016-11-10 2016-11-09 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
M - Exercise -1,000 15,768 -5.96
2016-11-10 2016-11-09 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 1,000 22,453 4.66 23.85 23,850 535,504
2016-09-26 2016-09-22 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Options (right to buy)
M - Exercise X -7,000 65,007 -9.72 13.90 -97,300 903,597
2016-09-26 2016-09-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -7,000 21,453 -24.60 60.00 -420,000 1,287,180
2016-09-26 2016-09-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 28,453 32.63 13.90 97,300 395,497
2016-09-21 2016-09-19 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Options (right to buy)
M - Exercise X -8,000 72,007 -10.00 13.90 -111,200 1,000,897
2016-09-21 2016-09-19 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -1,304 21,453 -5.73 50.00 -65,200 1,072,650
2016-09-21 2016-09-19 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
A - Award 19,125 22,757 526.57
2016-09-21 2016-09-19 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
A - Award 464 3,632 14.65
2016-09-21 2016-09-19 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -8,000 3,168 -71.63 50.00 -400,000 158,400
2016-09-21 2016-09-19 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 8,000 11,168 252.53 13.90 111,200 155,235
2016-09-02 2016-08-31 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -898 3,168 -22.09 26.07 -23,411 82,590
2016-03-02 2016-02-29 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 25,090 25,090
2016-03-02 2016-02-29 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
A - Award 4,910 4,910
2016-03-02 2016-02-29 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 29,583 29,583
2016-03-02 2016-02-29 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
A - Award 417 417
2016-03-02 2016-02-29 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
A - Award 2,762 4,066 211.81
2015-04-22 2015-02-27 4/A SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 80,007 80,007
2015-04-22 2015-02-27 4/A SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
A - Award 5,993 5,993
2015-03-03 2015-02-27 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 76,397 76,397
2015-03-03 2015-02-27 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
A - Award 9,603 9,603
2014-03-04 2014-02-28 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 52,708 52,708
2014-03-04 2014-02-28 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
A - Award 2,292 2,292
2013-06-07 2013-06-04 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award -45,000 45,000 -50.00
2013-06-07 2013-06-04 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award -42,137 42,137 -50.00
2013-06-07 2013-06-04 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
A - Award -2,863 2,863 -50.00
2012-11-07 2012-11-05 4 SRPT Sarepta Therapeutics, Inc.
Stock Option (right to buy)
A - Award -150,000 150,000 -50.00
2012-02-06 2012-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 68,750 68,750
2012-02-06 2012-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 10,166 19,437 109.65 0.01 102 194
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)